Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
Sales | 4,819,000 | 4,626,000 | 5,076,000 | 5,372,000 | 5,129,000 |
Cost of Goods | 1,500,000 | 1,357,000 | 1,525,000 | 1,929,000 | 1,852,000 |
Gross Profit | 3,319,000 | 3,269,000 | 3,551,000 | 3,443,000 | 3,277,000 |
Operating Expenses | 2,242,000 | 2,163,000 | 2,382,000 | 2,127,000 | 2,126,000 |
Operating Income | 1,077,000 | 1,106,000 | 1,169,000 | 1,316,000 | 1,151,000 |
Other Income | -308,000 | 358,000 | -246,000 | 45,000 | 96,000 |
Pre-tax Income | 769,000 | 1,464,000 | 923,000 | 1,361,000 | 1,247,000 |
Income Tax | 118,000 | 396,000 | 292,000 | 345,000 | 262,000 |
Net Income Continuous | 523,000 | 961,000 | 506,000 | 906,000 | 902,000 |
Net Income Discontinuous | 4,000 | 3,000 | N/A | N/A | N/A |
Net Income | $527,000 | $964,000 | $506,000 | $906,000 | $902,000 |
EPS Basic Total Ops | 0.27 | 0.50 | 0.26 | 0.47 | 0.47 |
EPS Basic Continuous Ops | 0.27 | 0.50 | 0.26 | 0.47 | 0.47 |
EPS Diluted Total Ops | 0.27 | 0.49 | 0.26 | 0.47 | 0.46 |
EPS Diluted Continuous Ops | 0.27 | 0.49 | 0.26 | 0.47 | 0.46 |
EBITDA(a) | $1,289,000 | $1,310,000 | $1,404,000 | $1,507,000 | $1,336,000 |